Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12,246 GBX | -0.58% | +1.06% | +15.53% |
02:05pm | ASTRAZENECA : Buy rating from JP Morgan | ZD |
13/05 | AstraZeneca Sued by Trial Participant For Alleged Injury During COVID-19 Vaccine Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.53% | 24TCr | |
+29.82% | 68TCr | |
+30.35% | 59TCr | |
-3.74% | 36TCr | |
+17.49% | 33TCr | |
+3.52% | 28TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+7.34% | 17TCr | |
-1.65% | 16TCr |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- AstraZeneca Q1 Core Earnings, Revenue Increase -- Shares Jump Premarket